InvestorsHub Logo
Followers 10
Posts 362
Boards Moderated 0
Alias Born 06/22/2018

Re: marjac post# 344644

Wednesday, 06/23/2021 1:34:15 PM

Wednesday, June 23, 2021 1:34:15 PM

Post# of 423943
So that what is the case Amarin is fighting?

Hikma has insulated them from any induced infringement claim. Does Hikma's reliance on FDA AB rating enough to convince the judge?


@marjac Regarding the generic, I posted under @captbeer 's post.

Since Hikma has posted the MSDS sheet on their website, we have to assume it is true.

They are selling a misbranded drug. No evidence need to be provided. There is no way that with 80% as the max (100% pure content of EPA), they can have a bioequivalent product.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News